Not applicableStudy completedNCT03061955
What this trial is testing
Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)
Who this might be right for
Influenza Virus Vaccine Adverse Reaction (Disorder)InfluenzaMalignancy
Wake Forest University Health Sciences 28